首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1619082

體外診斷市場規模、佔有率、成長分析、按產品、按技術、按檢體、按測試類型、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

In-Vitro Diagnostics Market Size, Share, Growth Analysis, By Product (Reagents & Kits, Instruments), By Technology (Immunoassays, Clinical Chemistry), By Specimen, By Test Type, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球體外診斷市場規模預估為835億美元，從2023年的879.3億美元成長到2031年的1,329億美元，預測期間（2024-2031年）複合年成長率為5.3%。

由於慢性病盛行率上升以及消費者對早期準確診斷解決方案的需求不斷增加，體外診斷市場預計將成長。對醫療研發和技術進步的投資將進一步增強體外診斷公司的能力。此外，人口老化、疾病檢測需求的快速增加以及個人化醫療的不斷成長趨勢為市場參與者提供了巨大的商機。然而，高昂的開發成本、嚴格的監管要求和有限的報銷選擇等挑戰可能會阻礙長期需求。整體而言，相關人員需要駕馭這些動態，以充分利用 2023 年及以後體外診斷領域充滿希望的成長前景。

市場概況
免疫檢測
- 酵素免疫分析法測定法 (ELISA)
- 化學冷光免疫檢測
- 螢光測定
- 快速測試
- 酵素連結免疫斑點測定法（Elispot）
- 蛋白質印跡法
- 其他
臨床化學
- 基礎代謝組
- 肝臟組
- 腎臟概況
- 血脂譜
- 甲狀腺功能檢查
- 電解質板
- 特殊化學測試
分子診斷
- 聚合酵素鏈鎖反應(PCR)
- 恒溫核酸增幅技術（INAAT）
- DNA定序與次世代定序(NGS)
- 原位雜合技術（ISH）
- DNA微陣列
- 其他
血液學
微生物學
凝血和止血
尿液檢查
層析法和質譜分析

體外診斷市場規模：依檢體及複合年成長率（2024-2031）

市場概況
血
血清
電漿
唾液
尿

體外診斷市場規模：依測試類型及複合年成長率（2024-2031）

市場概況
臨床檢查
就地檢驗

體外診斷市場規模：按應用和複合年成長率（2024-2031）

市場概況
感染疾病
腫瘤學
內分泌學
心臟病學
驗血
基因檢測
自體免疫疾病
過敏診斷
藥物監測和檢測
骨骼和礦物質疾病
血液凝固檢驗
血型分類
其他用途

體外診斷市場規模：依最終用戶和複合年成長率（2024-2031）

市場概況
醫院/診所
臨床實驗室
血庫
家庭護理設置
製藥和生物技術公司
學術機構
其他最終用戶

體外診斷市場規模及複合年成長率（2024-2031）

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Roche
Siemens Healthineers
Thermo Fisher Scientific
Abbott Laboratories
bioMerieux
Bio-Rad Laboratories
QIAGEN
Agilent Technologies
Sysmex Corporation
Fujifilm Holdings
Illumina
Shimadzu Corporation
DiaSorin
Grifols
Quest Diagnostics
Transasia Bio-Medicals
Tulip Diagnostics
NeoDx
Voxtur Bio
Peerless Biotech

結論和建議

簡介目錄

Product Code: SQSG35G2015

Global In-Vitro Diagnostics Market size was valued at USD 83.50 Billion in 2022 and is poised to grow from USD 87.93 Billion in 2023 to USD 132.90 Billion by 2031, growing at a CAGR of 5.3% during the forecast period (2024-2031).

The in-vitro diagnostics market is poised for growth, driven by the rising prevalence of chronic diseases and an increasing consumer demand for early and precise diagnostic solutions. Investments in medical research and development, along with advancements in technologies, will further enhance the capabilities of in-vitro diagnostics firms. Additionally, an aging population, a surge in disease testing requirements, and the growing trend towards personalized medicine present substantial opportunities for market players. Nonetheless, challenges such as high development costs, stringent regulatory requirements, and limited reimbursement options may hinder long-term demand. Overall, stakeholders should navigate these dynamics to capitalize on the promising growth landscape within the in-vitro diagnostics sector through 2023 and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In-Vitro Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In-Vitro Diagnostics Market Segmental Analysis

Global In-Vitro Diagnostics Market is segmented by Product, Technology, Specimen, Test Type, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits, Instruments, Data Management Software & Services. Based on Technology, the market is segmented into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Chromatography & Mass Spectrometry. Based on Specimen, the market is segmented into Blood, Serum, Plasma, Saliva, Urine. Based on Test Type, the market is segmented into Laboratory Tests, Point-Of-Care Tests. Based on Application, the market is segmented into Infectious Diseases, Oncology, Endocrinology, Cardiology, Blood Screening, Genetic Testing, Autoimmune Diseases, Autoimmune Diseases, Allergy Diagnostics, Drug Monitoring & Testing, Bone & Mineral Disorders, Coagulation Testing, Blood Group Typing, Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Blood Banks, Home Care Settings, Pharmaceutical & Biotechnology Companies, Academic Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market is significantly influenced by several key drivers. Rapid advancements in technology and the growing demand for early and accurate disease detection are paramount in propelling market growth. Additionally, the increasing prevalence of chronic and infectious diseases, along with the rise in patient awareness regarding health monitoring, further fuels the market. Government initiatives promoting healthcare access and investments in research and development also contribute to the expansion of this sector. Furthermore, the aging population, which demands advanced diagnostic solutions, is another critical factor driving the growth of the In-Vitro Diagnostics market globally.

Restraints in the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market faces several constraints that may hinder its growth. Factors such as stringent regulatory requirements, which vary significantly by region, can complicate the approval process for new diagnostic products. Furthermore, the high costs associated with research and development pose a significant barrier, particularly for smaller firms lacking substantial financial resources. Additionally, the increasing competition among established players and emerging startups can lead to market saturation, driving prices down and affecting profitability. Lastly, the ongoing challenges related to data privacy and cybersecurity in healthcare can create further obstacles for innovation and market expansion in the in-vitro diagnostics sector.

Market Trends of the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market is experiencing a significant trend toward home care solutions, driven by increasing consumer demand for convenience and accessibility. This shift is prompting in-vitro diagnostics companies to innovate and develop user-friendly test kits designed for at-home use, negating the need for medical supervision. As healthcare systems evolve and patients seek personalized and immediate testing options, these developments represent a lucrative opportunity for manufacturers. By capitalizing on the growing popularity of homecare, the in-vitro diagnostics sector is poised for robust revenue growth, while also improving patient engagement and outcomes on a global scale.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Customer & Buying Criteria Analysis

Global In-Vitro Diagnostics Market Size by Product & CAGR (2024-2031)

Market Overview
Reagents & Kits
Instruments
Data Management Software & Services

Global In-Vitro Diagnostics Market Size by Technology & CAGR (2024-2031)

Market Overview
Immunoassays
- Enzyme-Linked Immunosorbent Assays (ELISA)
- Chemiluminescence Immunoassays
- Immunofluorescence Assays
- Rapid Tests
- Enzyme-Linked Immunospot Assays (Elispot)
- Western Blotting
- Other
Clinical Chemistry
- Basic Metabolic Panels
- Liver Panels
- Renal Profiles
- Lipid Profiles
- Thyroid Function Panels
- Electrolyte Panels
- Specialty Chemical Tests
Molecular Diagnostics
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Sequencing & Next-Generation Sequencing (NGS)
- In Situ Hybridization (ISH)
- DNA Microarrays
- Other
Hematology
Microbiology
Coagulation & Hemostasis
Urinalysis
Chromatography & Mass Spectrometry

Global In-Vitro Diagnostics Market Size by Specimen & CAGR (2024-2031)

Market Overview
Blood
Serum
Plasma
Saliva
Urine

Global In-Vitro Diagnostics Market Size by Test Type & CAGR (2024-2031)

Market Overview
Laboratory Tests
Point-Of-Care Tests

Global In-Vitro Diagnostics Market Size by Application & CAGR (2024-2031)

Market Overview
Infectious Diseases
Oncology
Endocrinology
Cardiology
Blood Screening
Genetic Testing
Autoimmune Diseases
Autoimmune Diseases
Allergy Diagnostics
Drug Monitoring & Testing
Bone & Mineral Disorders
Coagulation Testing
Blood Group Typing
Other Applications

Global In-Vitro Diagnostics Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals & Clinics
Clinical Laboratories
Blood Banks
Home Care Settings
Pharmaceutical & Biotechnology Companies
Academic Institutes
Other End Users

Global In-Vitro Diagnostics Market Size & CAGR (2024-2031)

North America, (Product, Technology, Specimen, Test Type, Application, End User)
- US
- Canada
Europe, (Product, Technology, Specimen, Test Type, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Technology, Specimen, Test Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Technology, Specimen, Test Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Technology, Specimen, Test Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transasia Bio-Medicals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tulip Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoDx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Voxtur Bio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Peerless Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments